Iovance Biotherapeutics Up Over 37%, on Pace for Largest Percent Increase Since June 2016 -- Data Talk
Dow Jones2026/08/06 15:13Iovance Biotherapeutics Inc (IOVA) is currently at $5.97, up $1.63 or 37.56%
--Would be highest close since Feb. 5, 2025, when it closed at $6.10
--On pace for largest percent increase since June 3, 2016, when it rose 43.45%
--Currently up three of the past four days
--Up 118.68% year-to-date
--Down 96.25% from its all-time closing high of $159.00 on June 7, 2011
--Up 126.14% from 52 weeks ago (Aug. 7, 2025), when it closed at $2.64
--Would be a new 52-week closing high
--Up 229.83% from its 52-week closing low of $1.81 on Nov. 5, 2025
--Traded as high as $6.39; highest intraday level since Jan. 27, 2025, when it hit $6.50
--Up 47.24% at today's intraday high; largest intraday percent increase since May 16, 2019, when it rose as much as 47.64%
All data as of 11:10:27 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 06, 2026 11:13 ET (15:13 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Presents Both Danger and Opportunity! ETFs Are Strengthening, But This Data Is Alarming!
XRP Traders Target $1.90 as On-Chain Ledger Value Expands 43 Times to $4.26 Billion

Deka Immobilien sells Novotel Freiburg am Konzerthaus to IREMIS
Following Novartis, Novo Nordisk (NVO.US) terminates two cardiovascular clinical trials.
Novo Nordisk (NVO.US) has terminated two additional clinical trials of its experimental cardiovascular drug.
